Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

A Novel Anti-Glypican-3 Monoclonal Antibody G<sub>3</sub>Mab-25 for Versatile Applications.

Monoclonal antibodies in immunodiagnosis and immunotherapy·2026
Same authorSame journal

Epitope Mapping of Anti-mouse ACKR4 Monoclonal Antibodies Developed by N-Terminal Peptide Immunization.

Monoclonal antibodies in immunodiagnosis and immunotherapy·2026
Same authorSame journal

Epitope Mapping of Anti-Mouse C-C Motif Chemokine Receptor 1 Monoclonal Antibodies Developed by the Cell-Based Immunization and Screening Method.

Monoclonal antibodies in immunodiagnosis and immunotherapy·2026
Same author

Chimeric Anti-Glypican 1 Antibodies Exert Antitumor Activities in Xenograft Models of Lung and Pancreatic Cancers.

International journal of molecular sciences·2026
Same author

Ca<sub>13</sub>Mab-17, a Novel Anti-Cadherin-13 Monoclonal Antibody for Versatile Applications.

Antibodies (Basel, Switzerland)·2026
Same authorSame journal

Establishment of a Novel Anti-EphA4 Monoclonal Antibody, Ea<sub>4</sub>Mab-3, for Versatile Applications.

Monoclonal antibodies in immunodiagnosis and immunotherapy·2026

Related Experiment Video

Updated: Oct 2, 2025

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

9.7K

Epitope Mapping of Rituximab Using HisMAP Method.

Teizo Asano1, Hiroyuki Suzuki2, Mika K Kaneko1

  • 1Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
|February 28, 2022
PubMed
Summary

Researchers identified two key regions on CD20, PANPSE and CYSIQ, crucial for rituximab binding. This finding enhances understanding of anti-CD20 monoclonal antibody mechanisms for B cell lymphoma treatments.

Keywords:
CD20His tagepitope mappingmonoclonal antibodyrituximab

More Related Videos

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.1K
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.9K

Related Experiment Videos

Last Updated: Oct 2, 2025

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

9.7K
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.1K
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.9K

Area of Science:

  • Immunology
  • Oncology
  • Biochemistry

Background:

  • CD20 is a B lymphocyte surface antigen targeted for treating B cell lymphomas and autoimmune diseases.
  • Anti-CD20 monoclonal antibodies (mAbs), including rituximab, have been developed for therapeutic applications.
  • Understanding the antigen recognition mechanism of mAbs is vital for optimizing antibody function and vaccine development.

Purpose of the Study:

  • To precisely determine the binding epitope of rituximab on the CD20 antigen.
  • To elucidate the molecular interactions between rituximab and CD20 for improved therapeutic strategies.

Main Methods:

  • Utilized the histidine-tag insertion for epitope mapping (HisMAP) method.
  • Investigated the critical amino acid residues involved in rituximab-CD20 binding.

Main Results:

  • Identified two significant regions on CD20: residues 169-174 (PANPSE) and 183-187 (CYSIQ).
  • These regions were confirmed as important for rituximab binding to CD20, refining previous findings.

Conclusions:

  • The study precisely mapped the rituximab binding epitope on CD20, identifying two key functional regions.
  • These findings contribute to a deeper understanding of anti-CD20 mAb mechanisms and inform the development of next-generation therapies for B cell malignancies.